Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2006;91:802-804; doi:10.1136/adc.2006.098616
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

PERSPECTIVE

Endocrinology

Very high dose inhaled corticosteroids: panacea or poison?

G Russell

Correspondence to:
Correspondence to:
Dr G Russell
Department of Child Health, University of Aberdeen, Royal Aberdeen Children’s Hospital, Aberdeen AB25 2ZG, UK; libra@ifb.co.uk


Perspective on the paper by Paton et al (see page 808)

Keywords: asthma; adrenal cortex hormones; adrenal insufficiency; fluticasone

The first 150 words of the full text of this article appear below.

Only the older readers of Archives will remember a time when inhaled corticosteroid therapy (ICT) was not the mainstay of asthma treatment. In the 1960s asthma was an unpredictable and more or less untreatable disease, and the diagnosis was made with reluctance by doctors and accepted with dismay by parents. The therapeutic options were limited. For acute relief, isoprenaline (isoproterenol) was given by pressurised metered dose inhaler, but its effects lasted for only a few minutes, and it fell into disrepute after only a decade, when its use appeared to be associated with increased mortality.1 In hospital, subcutaneous adrenaline backed up by oral or intravenous corticosteroids was the mainstay of therapy. Interval management was mainly with bronchodilators such as ephedrine, theophylline, and the belladonna alkaloids, and compound preparations such as Tedral, an unlikely mixture of theophylline, ephedrine, and phenobarbital, were popular. These drugs were of undoubted benefit, but disappointingly . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

A brief digest of the October issue
Arch. Dis. Child. 2006 91: e6. [Extract] [Full Text] [PDF]

Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone
J Paton, E Jardine, E McNeill, S Beaton, P Galloway, D Young, and M Donaldson
Arch. Dis. Child. 2006 91: 808-813. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Newcombe, P. A., Sheffield, J. K., Juniper, E. F., Marchant, J. M., Halsted, R. A., Masters, I. B., Chang, A. B. (2008). Development of a Parent-Proxy Quality-of-Life Chronic Cough-Specific Questionnaire*: Clinical Impact vs Psychometric Evaluations. Chest 133: 386-395 [Abstract] [Full Text]  
  • Townshend, J, Hails, S, Mckean, M (2007). Management of asthma in children. BMJ 335: 253-257 [Full Text]  

eLetters:

Read all eLetters

High-Dose Inhaled Fluticasone, Adrenal Crisis and a Fatal Accident Inquiry
geoffrey todd
ADC Online, 27 Nov 2006 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs